In conclusion, the findings from the present study suggest that the down-regulation of GPI-PLD inhibits the release of the GPI-anchored prion protein (PrPC) from the CEM, resulting in more interaction with the injected scrapie prion protein (PrPSc) as the disease progresses. This evidence concerns the gene PRNP and scrapie.